INTRODUCTION TO THE METAGENOMI CLASS ACTION LAWSUIT
Call Timothy L. Miles today for a free case evaluation in the Metagenomi class action lawsuit
The Metagenomi class action lawsuit seeks to represent purchasers of Metagenomi Inc. (NASDAQ: MGX) stock pursuant and/or traceable to Metagenomi’s registration statement issued in connection with Metagenomi’s initial public offering (“IPO”) held between February 9 and 13, 2024. Captioned Vreeland v. Metagenomi Inc., No. 24-cv-06765 (N.D. Cal.), the Metagenomi class action lawsuit charges Metagenomi and certain of Metagenomi’s top executives and directors with violations of the Securities Act of 1933.
If you have suffered losses in Metagenomi stock and are interested in becoming the lead plaintiff in the Metagenomi class actionlawsuit or have any inquiries regarding your rights as a shareholder, please reach out to Metagenomi Stock Loss Lawyer Timothy L. Miles at no cost. You can contact him by calling 855/846-6529, sending an e-mail to [email protected], or filling out a contact form.
Lead plaintiff motions for the Metagenomi class action lawsuit must be filed with the court no later than November 25, 2024.
allegations in the Metagenomi class action lawsuit
Metagenomi introduced itself to investors during its IPO as a “genetic medicines company” having a long-standing business relationship with Moderna, Inc., one of the leading Covid-19 vaccine companies, according to the complaint.
The Metagenomi class action lawsuit alleges that the IPO’s offering documents provided false and/or materially misleading information concerning Metagenomi’s collaboration agreement with Moderna.
The Metagenomi class action lawsuit further alleges that on May 1, 2024, Metagenomi announced that it and Moderna had “mutually agreed to terminate their collaboration” agreement. On this news, the price of Metagenomi stock fell more than 12%, according to the complaint. Since the IPO, the price of Metagenomi stock has fallen substantially below its $15.00 per share IPO price.
THE LEAD PLAINTIFF DEADLINE IN THE Metagenomi class action lawsuit
Lead plaintiff motions for the Metagenomi class action lawsuit must be filed with the court no later than November 25, 2024. When a securities class action is filed such as the Metagenomi class actionlawsuit:
Anyone who wants to be lead plaintiff on behalf of the class must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published.
YOU HAVE TWO CHOICES IF YOU RECEIVE A NOTICE IN THE Metagenomi CLASS ACTION LAWSUIT
First, read the notice very carefully. You have two choices.
First, you can do nothing and remain a member of the class represented by lead counsel.
Second, if you believe you have a large enough loss to justify it, you can opt out of the Metagenomi class actionlawsuit and file your own separate lawsuit.
Note, that if you opt-out, you will not be able to participate in any settlement or recovery obtained in the Metagenomi class actionlawsuit.
THE LEAD PLAINTIFF PROCESS IN THE Metagenomi CLASS ACTION LAWSUIT
The Private Securities Litigation Reform Act of 1995 (PSLRA) permits any investor who purchased and suffered losses in Metagenomi stock to seek appointment as lead plaintiff in the Metagenomi class actionlawsuit.
A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.
A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit.
Having a voice in decision-making processes regarding the settlement.
No financial risk, as lead counsel covers all costs and expenses and are paid only if they secure a settlement or judgment recovery for the class
Potentially enjoying long-term benefits from governance reform resulting from the litigation.
ELIGIBILITY CRITERIA FOR LEAD PLAINTIFF APPOINTMENT
To be eligible for appointment as the lead plaintiff in the Metagenomi class action lawsuit, an investor must meet the following criteria:
Securities Acquisition: The investor must have purchased Metagenomi Inc. (NASDAQ: MGX) stock pursuant and/or traceable to Metagenomi’s registration statement issued in connection with Metagenomi’s initial public offering (“IPO”) held between February 9 and 13, 2024.
Financial Losses: The investor must have suffered financial losses as a direct result of the alleged securities fraud perpetrated by Metagenomi and its executives.
Typicality and Adequacy: The investor's legal claims must be typical of those asserted on behalf of the class, and they must demonstrate their ability to adequately represent the interests of the entire class through experience, resources, and the absence of conflicts of interest.
It is crucial to note that both domestic and international investors who meet these criteria are eligible to seek appointment as the lead plaintiff in the Metagenomi class action lawsuit, as courts have consistently recognized the rights of non-U.S. investors in securities class actions.
LEGAL REQUIREMENTS FOR PREVAILING IN THE Metagenomi CLASS ACTION LAWSUIT
Instead, the attorney's fees and expenses are deducted from any settlement or judgment recovered on behalf of the class, typically as a court-approved percentage of the total recovery.
This arrangement ensures that investors can pursue their legal rights without bearing the financial burden of costly litigation, as the attorneys assume the risk and only receive compensation if they achieve a successful outcome for the class.
FREQUENTLY ASKED QUESTIONS ABOUT THE Metagenomi CLASS ACTION LAWSUIT
Can I serve as a lead plaintiff in the class action against Metagenomi if I purchases shares outside of the class period?
No. Even if you suffered losses in Metagenomi stock, if you purchased securities outside of the Class period, you will not be able to participate in the Metagenomi class actionlawsuit.
Can I serve as a lead plaintiff in the class action against Metagenomi if I am serving as lead plaintiff in another securities fraud case?
Yes, unless you have been a lead plaintiff in more than five securities class actions during any three-year period which is expressly prohibited by the securities laws. Otherwise, if you suffered losses in Metagenomi stock, you may move to be appointed lead plaintiff in the Metagenomi lawsuit.
Can the court appoint more than one lead plaintiff in the Metagenomi class action lawsuit?
Yes, at its discretion the Court may appoint a person, entity, or group of persons and/or entities as Lead Plaintiffs in the Metagenomi class action lawsuit.
How do I know if I am a member of the class in the class action against Metagenomi?
If you purchased shares during the class period and suffered losses in Metagenomi stock, then you are most likely a member of the class in the Metagenomi class actionlawsuit and may participate in the Metagenomi lawsuit since you suffered losses in STMicroelectronics class actionlawsuit.
Resources for Investors in the Metagenomi Class Action Lawsuit and Others
CONTACT Metagenomi STOCK LOSS LAWYER TODAY TIMOTHY L. MILES TODAY ABOUT A Metagenomi CLASS ACTION LAWSUIT
If you suffered losses in Metagenomi stock, contact Metagenomi stock loss lawyer Timothy L. Miles today for a free case evaluation about a Metagenomi class action lawsuit. Call today and see what a Metagenomi stock loss lawyer could do for you if you suffered losses in Metagenomistock. This will most likely be the only call you need to make. (855) 846–6529 or [email protected].
METAGENOMICLASS ACTION LAWSUIT METAGENOMI STOCK LOSS LAWYER TIMOTHY L. MILES 300 CENTERVIEW DR, UNIT 247 BRENTWOOD, TN 27027 855-846-6528
FREE CASE EVALUATION: CLASS ACTION AGAINST METAGENOMI If you suffered losses in Metagenomi stock, call Metagenomi stock loss lawyer Timothy L. Miles today for a free case evaluation about a Metagenomiclass action lawsuit. 855-846-6528
Call Timothy L. Miles today for a free case evaluation in the Metagenomi class action lawsuit
Give Metagenomi stock loss lawyer Timothy L. Miles a call about the Metagenomi class action lawsuit
